Drug Controller General Of India Rsquo

Rediff.com » News » Drug Controller General Of India Rsquo

News for Drug Controller General Of India Rsquo

News
Business

Does India have enough vaccine reserves to combat another Covid wave?

Vaccine makers in India have a limited stockpile of doses, even as COVID-19 threatens to rear its head this winter season, reports Sohini Das. IMAGE: A beneficiary is being inoculated with a......

India probes four cough syrups after 66 Gambian children's deaths

India's drug regulator has initiated a probe and sought further details from the WHO after the global health body issued an alert that cough syrups manufactured by an Indian firm could potentially......

India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

This could also be India's first vaccine for children aged 12 years and above as the company has conducted trials on the age group. The decision, however, lies with the regulator, reports Sohini......

India will wait for DCGI nod to restart Oxford vaccine trial

The global trials were halted after a study participant suffered a ‘potentially unexplained illness', reports Sohini Das. IMAGE: Serum Institute of India is the Indian partner of AstraZeneca......

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

India is not keen to ‘bow down’ to demands related to indemnity against legal liabilities in case any vaccine recipient develops severe adverse reactions post inoculation. Even as......

Pharma cos okay with QR codes to combat counterfeit drugs

As the Drugs Controller General of India (DCGI) is set to crack down on companies to ensure compliance with printing QR codes on top-selling brands to curb counterfeiting, top pharma companies say......

What is Schedule M and why it's mandatory for all pharma units

With an eye on improving quality assurance in the wake of increased global scrutiny on Indian pharma products, the Centre on Tuesday said that Schedule M of the Drugs and Cosmetics Act, 1940 will......

How govt plans to ensure faster availability of new drugs

Given the stringent nature of India’s regulatory environment for clinical trials, several pharmaceutical companies have moved their trials out of India. As a result, only 1.2 per cent of......

Are Ranbaxy drugs available in India safe?

At a time India-made medicines appear to be losing sheen the world over, the country’s top regulator, the Drug Controller General of India (DCGI), is struggling to ensure quality of drugs in......

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

The concerns surrounding drug manufacturing practices in India appear to have reached foreign shores, beyond the international regulators’ domain. Ranbaxy whistle-blower Dinesh Thakur,......

Rediff News

Drug Controller General Of India Rsquo

News for Drug Controller General Of India Rsquo

Does India have enough vaccine reserves to combat another Covid wave?

India probes four cough syrups after 66 Gambian children's deaths

India could get 4th Covid vaccine as Zydus Cadila set to seek nod for ZyCoV-D

India will wait for DCGI nod to restart Oxford vaccine trial

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

Pharma cos okay with QR codes to combat counterfeit drugs

What is Schedule M and why it's mandatory for all pharma units

How govt plans to ensure faster availability of new drugs

Are Ranbaxy drugs available in India safe?

Ranbaxy whistle-blower to talk on quality of Made-in-India drugs

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS